Background
==========

The Y chromosome has demonstrated its utility, for a number of years, in shedding light on human history and identifying population affinities. Given that human genome variation evolves over time due to several factors - among them mutation, genetic drift, migration and selection - the genome has retained some of the record of these historical and evolutionary events. This record is more easily read from the Y chromosome due to the lack of recombination along most of its length and a strict paternal mode of transmission. Consequently, the Y chromosome has become a marker of the male contribution to the shaping of human populations and their histories.

A standard nomenclature established by the Y Chromosome Consortium \[[@B1]\] resolved the global pattern of Y chromosome variation into 18 major haplogroups that were classified using capital letters A through to R. This has recently been revised by Karafet *et al.*\[[@B2]\] to a Y chromosome haplogroup phylogeny that contains 311 branches delineated by approximately 600 markers (primarily bi-allelic) and includes an additional two haplogroups (S and T), increasing the major haplogroup number to 20. The frequency and distribution of these haplogroups shows good concordance with the geographic distribution of populations. This, together with high levels of population differentiation, \[[@B3]\] have added value to the Y chromosome as a tool for reconstructing the history and migrations of humans over time.

While Y chromosome short tandem repeats (STRs) are now used routinely in forensic analysis \[[@B4]\], the use of bi-allelic markers - mainly single nucleotide polymorphisms (SNPs) - which designate Y chromosome haplogroups, is advancing steadily due to their ability to provide information on the geographic origin of individuals. Their use, however, is hindered by the paucity of simple screening methods and insufficient knowledge of their global distribution. However, this has improved in recent years \[[@B5]\]

A number of assays for the rapid screening of Y chromosome haplogroups have been developed \[[@B6]-[@B9]\]. These were targeted primarily at resolving the major haplogroups found in European populations. While these studies have included in their assays a few SNPs to resolve the major Y chromosome haplogroups commonly found in sub-Saharan Africa, they do not contain the markers needed to resolve the majority of terminal branches of the Y chromosome phylogeny that exist among African populations.

In the present study, we report on the development of single base extension (SBE) assays used to refine the resolution of Y chromosome haplogroups commonly found in Africa, having also incorporated a few SNPs to delineate the common non-African Y chromosomes following a hierarchical screening process. SBE, due to its convenience and relative affordability, is now used in many genetic and forensic applications. Following the validation of the assays, we applied these methods in order to resolve the Y chromosome haplogroups in 683 male subjects, primarily from southern Africa. Haplogroup frequencies for the populations analysed were then calculated.

Results and discussion
======================

SNP selection and screening strategy
------------------------------------

Seven multiplex SBE assays, which incorporated 60 Y chromosome markers described in the YCC Phylogeny 2003 \[[@B10]\], were developed which resolved 61 Y chromosome haplogroups. The first multiplex, YSNP1, consisted of the markers SRY10831, M168, M89, M201, M69, M170, M172, M9, M207, M198 and M343 (Figure [1a](#F1){ref-type="fig"}). YSNP1 resolved Y chromosomes into either the African haplogroups (A, B or E) or Eurasian haplogroups found occasionally in African males \[unpublished restriction fragment length polymorphism (RFLP) data\]. Note: the marker, SRY10831, initially resolves haplogroup BR, while its reversion is used to define haplogroup R1a.

![**Electropherogram and phylogeny of (a) YSNP1, (b) Hg-A, (c) Hg-B, (d) Hg-B2b, (e) Hg-E, (f) Hg-E1b1a, and (g) Hg-E1b1b1**. The markers shown in parentheses are there to indicate the hierarchical nature of the phylogenies, and are not a part of the panels they are shown with.](2041-2223-1-6-1){#F1}

Any sample found to harbour the ancestral state at all markers within YSNP1 was screened using the multiplex assay, Hg-A. This multiplex consisted of the markers, M91, M31, M14, M114, P28, M28, M51, M13, M171 and M118 (Figure [1b](#F1){ref-type="fig"}) and was used to resolve the sub-clades of haplogroup A. Samples found to be derived at SRY10831, but ancestral at all other markers within YSNP1, were screened using the multiplex assay, Hg-B. This multiplex consisted of M60, M146, M182, M150, M152, M108, M43 and M112 (Figure [1c](#F1){ref-type="fig"}) and resolved the sub-clades of haplogroup B. Those samples with the derived allele at M112 were screened further, using the multiplex assay, Hg-B2b, which contained the markers P6, M115, M30, P7, P8 and M211 (Figure [1d](#F1){ref-type="fig"}), providing resolution of haplogroup B2b samples to the terminal branches of the phylogeny. While M108 recurs in haplogroup B2b resolving haplogroup B2b3a, its presence in the Hg-B multiplex assay should be sufficient to resolve both its occurrences in haplogroup B, thus negating the need to include it in the Hg-B2b assay.

Those samples found to be derived at SRY10831 and M168, while remaining ancestral at all other markers within YSNP1, could be assigned to haplogroups C, D or E. These samples were then screened using the Hg-E multiplex assay, which consisted of M40, M33, M44, M75, M41, M85, P2, M2 and M35 (Figure [1e](#F1){ref-type="fig"}). Samples found to be derived for M2 or M35 would fall into haplogroups E1b1a or E1b1b1, respectively. E1b1a Y chromosomes were further resolved using the assay, Hg-E1b1a; a multiplex comprised of the markers M58, M116, M149, M154, M155, M10 and M191 (Figure [1f](#F1){ref-type="fig"}). Those Y chromosomes assigned to haplogroup E1b1b1 were screened further using the multiplex assay, Hg-E1b1b1, which consisted of the markers M78, M148, M81, M107, M165, M123, M34, M136 and M281 (Figure [1g](#F1){ref-type="fig"}). When a sample was found to be ancestral for the M40 polymorphism, it was screened for the mutations that defined haplogroups C (M130) and D (M174) separately. This hierarchical screening approach facilitated the resolution of the relevant haplogroup in an individual after one, two, or at most, three reactions, depending on the haplogroup present.

Polymerase chain reaction (PCR) optimization
--------------------------------------------

While PCR primer concentrations were initially 0.02 μM - 0.04 μM, these were increased or decreased incrementally in order to obtain a relatively equal amplification of amplicons in the multiplex PCR (see Table [1](#T1){ref-type="table"}). The marker P28, in the Hg-A assay, initially experienced low amplification after multiplexing. This was rectified by increasing the final concentration of the P28 PCR primers to 0.2 μM, and decreasing the buffer concentration to 0.8×. The annealing temperature was also optimized in order to ensure maximum product yield and to minimize the formation of spurious products. A spurious amplification product was found to occur in the Hg-E1b1b1 assay which was eliminated by increasing the annealing temperature to 61°C.

###### 

Polymerase chain reaction (PCR) primer sequences, amplicon lengths and final PCR primer concentrations used in the study.

  SNP           Primer (5\' - 3\')                                          Fragment size (mers)   Concentration (μM)   Assay
  ------------- ----------------------------- ----------------------------- ---------------------- -------------------- -----------
  M170          CTAGTATGCTTCACACAAATGCG       GACCACACAAAAACAGGTCCTC        390                    0.08                 YSNP1
  M207          AAGGGCAAGCAAAATAGCAATAC       TGTTCGCTGCTACGAATCTTT         363                    0.08                 
  M201          CATGGGTAATTCGGTTGTTACC        CTAAACATCATGGTGTGACGAAC       331                    0.08                 
  M168          GGTTTGAATGAGACTGGGTCA         TGGTAATCTCATAGGTCTCTGACTG     295                    0.08                 
  M343          AGGTAGGAGGATCCAAAGCTGA        CACCTTTGTCCTCTTGCTCTTT        276                    0.08                 
  M9            TGCAGCATATAAAACTTTCAGGAC      TTCCTCATTTTTGAAGCTCGTG        241                    0.08                 
  M69           TCAGCCATTTCACCAAAACTCT        CTGAAGAAACAAACCTACCTGGAA      233                    0.08                 
  M89           CCAAGCTGGTGAGTCTTATCCT        GCAGAATAGCTGCTCAGGTACA        215                    0.08                 
  M172          CAGAAGATGCCCCATTATATCCT       ACTCCATGTTGGTTTGGAACAG        208                    0.08                 
  M198          TAGGCACTTGGGAACTTACACTC       TTCTTGTGATAGCATGCCGTTT        178                    0.08                 
  SRY10831      CATCCAGTCCTTAGCAACCATT        AATGACACAAGGCACCACATAG        163                    0.08                 
                                                                                                                        
  P28           TTTTGAGAGAAGACAAGGGGGATA      TTGGAGGGACATTATTCTCCTGA       559                    0.20                 Hg-A
  M13-M14\*     ATCACGCCCCTCTCATTGTC          AGCTCTAGATAAAAGCACATTGACACC   457                    0.08                 
  M91           GATCACAAAGACCTGGACAGATTACA    AACGGAAATGCCAAGAATCGTA        429                    0.05                 
  M31           GCTGAAACAATAGTTCTTCACAATGG    CAGTCCTATGCATAATGCCGTGT       400                    0.03                 
  M114          GCCTTGATTTTCTTCGTACTTCATAAG   CCAGTTTCTCACTGAGTTCATTCCTT    370                    0.06                 
  M28           GGGCTTCAGTTCTTGACGCTAC        CCGTCTTAATTTTGCGGTATTCAA      329                    0.04                 
  M51           AAACCACACCTGTCTTACCAGAGC      CTGTTCCCCAGTTTTCAATCTCC       293                    0.04                 
  M171          GGCTGTGTGGAGTATGTGTTGG        CAAATATCCTGCCCCAGCTTAGT       217                    0.04                 
  M118          TCCCTTGAAATTAAGGACAACAACT     CATTCTTCTCAACCAGCTGACACT      167                    0.06                 
                                                                                                                        
  M43           GACTCCATAAGCAAAAGGTCATCAA     AAAAGAAGTTGAGGACTGGAGCA       518                    0.12                 Hg-B
  M112          GGCCATGCTAACAGAGATCTGAC       CACAGTTCAATTCTTGTCTGTTGC      493                    0.08                 
  M152          AAGCAAAAAGCTCCTTCTGAGGT       CAGAAGGTGGATCAGGGTAGAAA       381                    0.08                 
  M182          CATTTTTGTGTCAGGTATCCTTTGT     CAAGACGGCGTATCAACTCAAG        368                    0.12                 
  M108          GCTTTTCTAACACCACCCATGAC       TATGTGATAGAGGTGGCTTTAAGTGG    342                    0.08                 
  M150          CCAGGCTAGCAGTGGAGATGAA        AGGGTGGACTGCTGACCTACTTT       312                    0.08                 
  M146          TTACAGGTGGAATGGGGTGTTAC       GAGAAGAACTGCCTTCCATGACATA     279                    0.08                 
  M60           CCTGATGTGGACTCAACCTTGTA       TGTTCATTATGGTTCAGGAGGAG       250                    0.08                 
                                                                                                                        
  M211          CACTGCACACACTACACTGACCAC      ATGTTGATTGGGTAGAGCCCTTT       386                    0.06                 Hg-B2b
  P6            TATTAGGGAAATCACTCAGGATGGT     TCTACGAATGTTTAACCTCAGATACCG   343                    0.12                 
  P8            AGTTGTTGGAAAGCCTCTGTTCA       TGATACTAGACGTGGCATCTTGTCA     313                    0.06                 
  M115          TGCCATGCTTGTTTCTTAATCCA       AACTATGTTGCACATCAGCCTCA       270                    0.12                 
  P7            GGCCAAAGCCTAGAATGAAATTG       AAGTGCTTGTCCAAGGCAGTATAA      228                    0.16                 
  M30           ACAAATCATGAGCTTACAGAACCTG     GGCACAGCCAGATAACCCTACA        200                    0.12                 
                                                                                                                        
  M40-M41\*     TAGCTGGTATGACAGGGGATGAT       GGGTAGGATAGGCTAGCTATTACGC     435                    0.08                 Hg-E
  M2            GGAGAAGAACGGAAGGAGTTCTAA      ACTTGCCAGAGACTTCCAGTTTG       372                    0.12                 
  M85†          GAACTGGCATCCAATACTAGCTGA      TCACCTCTTTTGTATTGGCTTCTTC     350                    0.08                 
  P2            TGGTCTGGTAACACCCATAAAGGT      GCAGTTTTCTCAGATGCTTCTCCTA     335                    0.08                 
  M35           GCCTAAAGAGCAGTCAGAGTAGAATG    GAGAATGAATAGGCATGGGTTCA       303                    0.08                 
  M75           GTCACATTCCACACATCAAGAAAACT    GTGAATCTCTGCCCAGAAAAGAAAA     274                    0.12                 
  M44           ATTGGATATGGAAGCCAGTCTCA       ATGTGTTTGAGGACCACCCTAGA       250                    0.12                 
  M33           GGCTTCTGTTCAATTTTCCTTTGAT     TTATTTGTTGAAGCCCCCAAGAG       223                    0.08                 
                                                                                                                        
  M10           GTTCAAGACAATGAAGGGAGAGACT     TGACATTGACCTGCAGCATAGG        520                    0.08                 Hg-E1b1ba
  M191          GAGCAAGTACAGCGAGCAGTAAG       GGTTTAACACAATGCAGGTCAATTC     480                    0.08                 
  M154†         CAATGGAGGCTATAGGTGATTGC       CTGTTTGTTCATGGAGATGTCTGTA     461                    0.08                 
  M149†         GAACTGGCATCCAATACTAGCTGA      TCACCTCTTTTGTATTGGCTTCTTC     350                    0.06                 
  M116          TATGAAGTACGAAGAAAATCAAGGCTA   TGGGTAGAAAAACTGCAAGTAGATGA    328                    0.12                 
  M58-M155\*    TGGGCCTGACCTCTTAACTTGTA       CATAATAAGCTAAGAAACATCCAGCCT   293                    0.06                 
                                                                                                                        
  M81†          CAATGGAGGCTATAGGTGATTGC       CTGTTTGTTCATGGAGATGTCTGTA     461                    0.10                 Hg-E1b1b1
  M123-M281\*   CTAATTCATGCTCTCAGGGGAAA       ATAACCTCTGGAAGTGTGTCTTTACCT   404                    0.10                 
  M107          AATCCCACCTCACATACACATAAGC     AGGGGTTGACAAGAAAAAGGAATA      386                    0.06                 
  M148†         GAACTGGCATCCAATACTAGCTGA      TCACCTCTTTTGTATTGGCTTCTTC     350                    0.08                 
  M78           ATGGCTGTATGGGTTTCTTTGACT      CGGAATATGGACAGTCATCGTATT      330                    0.08                 
  M165          CAAGTCAGCAAGGAGTAGGTGGA       TTGCACTGACACAAGTTATCTCCCT     293                    0.08                 
  M34           GATAACCTCATTGTGGAGAGCACTT     ATGCTAAAGCAAGTAACCCTGTGG      254                    0.10                 
  M136          ACCAACCGTATTACCTTCTCCTCA      CATGAGTCCAAAGTATAGTGGGCTA     226                    0.10                 

\* Due to the close proximity of the single nucleotide polymorphisms (SNPs), a single amplicon was used.

^†^Again, a single amplicon was used for these SNPs, but in different assays.

SBE optimization
----------------

The SBE primers designed for the seven SBE assays, ranging from 25 to 80 bases in length, were designed to differ by four to five bases within each assay (see Table [2](#T2){ref-type="table"}). This was not always reflected in the electropherogram, with a lack of uniform separation in most of the assays. This resulted in a few extension products (for example, M85 and P2 in Hg-E, M168 and M89 in Hg-YSNP1) co-migrating (see Figure [1](#F1){ref-type="fig"}). Fortunately, this did not interfere with the interpretation of results. The estimated lengths of extension products in the electropherogram (based on mobility) differed from the designed lengths, on average by four bases. This difference was ascribed to the migration rate of the primer (which was influenced by its actual length), possible secondary structure \[[@B11]\], mobility of the dye attached \[[@B12]\] and the use of POP-7^®^polymer. This was especially apparent for the M91 primer, a 25-base primer which sized, on average, 11 bases larger. Despite these observations, profiles generated by all the assays were usually easily interpreted.

###### 

Single base extension (SBE) primer sequences and final concentrations used in the study, grouped by assay.

  SNP             SBE primer (5\' - 3\')                           Size (mers)   Concentration (μM)   Assay
  ---------- ---- ------------------------------------------------ ------------- -------------------- -----------
  SRY10831   FW   (C)~3~CTCTTGTATCTGACTTTTTCACACAGT                30            0.10                 YSNP1
  M168       FW   (C)~12~TGGAGTATGTGTTGGAGGTGAGT                   35            0.40                 
  M89        RV   (GACT)~2~(C)~10~CAACTCAGGCAAAGTGAGAGAT           40            0.40                 
  M201       FW   (GACT)~2~(C)~9~AGATCTAATAATCCAGTATCAACTGAGG      45            0.40                 
  M69        FW   (GACT)~4~(C)~11~GGAGGCTGTTTACACTCCTGAAA          50            0.40                 
  M170       FW   (GACT)~4~(C)~9~ACTATTTTATTTACTTAAAAATCATTGTTC    55            0.80                 
  M172       FW   (GACT)~7~(C)~12~CCAAACCCATTTTGATGCTT             60            0.40                 
  M9         FW   (GACT)~8~(C)~11~AAACGGCCTAAGATGGTTGAAT           65            0.40                 
  M207       FW   (GACT)~8~(C)~11~GCAAATGTAAGTCAAGCAAGAAATTTA      70            0.80                 
  M198       FW   (GACT)~9~(C)~9~TCAGTATACCAATTAATATTTTTGAAAGAG    75            0.80                 
  M343       FW   (GACT)~13~(C)~9~AGAGTGCCCTCGTGTTCCA              80            0.40                 
                                                                                                      
  M91        FW   CCTACATTGCTATTCTGTTTTTTTT                        25            0.60                 Hg-A
  M31        RV   (C)~8~CCACTGCTGTTCTGTCTACCA                      29            0.60                 
  M14        RV   (C)~5~CTTCATTAACTTTTTTAAACTGCTTATA               33            0.60                 
  M114       RV   (C)~15~AGCTGTACAAGGCTCTTCAAAT                    37            0.60                 
  P28        FW   (C)~14~GGTTAAAAGAAAAAAGCTCTCAGATAG               41            0.40                 
  M28        RV   (C)~27~TCGAGGTCCTCTGGCATC                        45            0.50                 
  M51        RV   (C)~29~CTCTGATCCCTGTTGGAAGC                      49            0.50                 
  M13        FW   (C)~31~GTAGGTTAAGGGCAAGACGGTTA                   54            0.60                 
  M171       RV   (C)~32~AGGTCTCTGACTGTTCAGTTTTATT                 57            0.50                 
  M118       RV   (C)~35~CAGCTGACACTTGTGTTTTCTTTATA                61            0.20                 
                                                                                                      
  M60        FW   (C)~3~TTACATTTCAAAATGCATGACTTAAAG                30            0.40                 Hg-B
  M146       RV   (C)~11~CTAAAACCCAGTGTTAATTACCCG                  35            0.80                 
  M182       FW   (C)~13~CTTAAAGCAGTGGTTAATGTAAACAAA               40            0.80                 
  M150       FW   (C)~22~TGCCCACACACACAGATAGAAGT                   45            0.80                 
  M152       FW   (C)~23~GCTTTCTCCTGATAATGTTCTTCTTCT               50            0.80                 
  M108       RV   (C)~27~CTTTTCTCTGACATTCAGGTATAGTTTC              55            0.30                 
  M43        FW   (C)~39~CTCTTTCCATGGCCAACAAAC                     60            0.40                 
  M112       FW   (C)~38~AAAGAGGTGAGATAAAAACAAAGCAGT               65            0.40                 
                                                                                                      
  P6         FW   (C)~3~TCAATAGAGGTTTCCACAGTTAAGTCT                30            0.10                 Hg-B2b
  M115       FW   (C)~3~CAGAGTTTAAATTAGTATTTGATTTCACATTA           35            0.80                 
  M30        FW   (C)~14~ATCATGTTTTAAGTCCTGACATCTGT                40            0.10                 
  P7         FW   (C)~21~CCATCACCTGGGTAAAGTGAATTA                  45            0.40                 
  P8         FW   (C)~27~GCAGCTCACCTTTCATTTAGGTC                   50            0.20                 
  M211       FW   (C)~30~TAGGCAAAAGGATGTTAACAACAAG                 55            0.80                 
                                                                                                      
  M40        RV   (C)~10~TCTTCACCCTGTGATCCGCT                      30            0.60                 Hg-E
  M33        FW   CGATCTGTTCAGTTTATCTCATAAGTTACTAGTTA              35            0.30                 
  M44        RV   (C)~11~AGGAAATCTCCTAACCTTCTAGTACACTG             40            0.40                 
  M75        FW   (C)~20~AAAAGACAATTATCAAACCACATCC                 45            0.10                 
  M41        FW   (C)~30~TGGCCAACATGGTGAAACTG                      50            0.50                 
  M85        RV   (C)~24~GCTTGTGTTCTATTAAGTGTAGTTTTGTTAG           55            0.20                 
  P2         RV   (GACT)~8~(C)~8~AGGTGCCCCTAGGAGGAGAA              60            0.40                 
  M2         RV   (GACT)~9~(C)~6~CCCTTTATCCTCCACAGATCTCA           65            0.60                 
  M35        RV   (GACT)~10~(C)~9~TTCGGAGTCTCTGCCTGTGTC            70            0.80                 
                                                                                                      
  M58        FW   (C)~5~ATTTATTGTCTTCTGCAGAATTGGC                  30            0.10                 Hg-E1b1a
  M116       FW   (C)~5~GCTTTCTGAAAAAATAATTTCAAACTGATA             35            0.40                 
  M149       FW   (C)~9~CTAACAAAACTACACTTAATAGAACACAAGC            40            0.10                 
  M154       RV   (C)~16~GTGTTACATGGCCTATAATATTCAGTACA             45            0.40                 
  M155       RV   (C)~23~AATTCAGAATATTTCATCTCTGGTCAC               50            0.40                 
  M10        FW   (C)~26~AATTTTTTTGTTTATTCCCAATGATCTTA             55            0.50                 
  M191       FW   (GACT)~5~(C)~10~ATTTACATTTTTTTCTTTACAACTTGACTA   60            0.40                 
                                                                                                      
  M78        FW   AATTGATACACTTAACAAAGATACTTCTTTC                  31            0.80                 Hg-E1b1b1
  M148       RV   (C)~7~TTTCTAGGTAACGTATGTAGACATTTCTG              36            0.80                 
  M81        FW   (C)~15~AGAGGTAAATTTTGTCCTTTTTTGAA                41            0.80                 
  M107       FW   (C)~18~TAAGCCAACGTATTAACCTTCTAATTTC              46            0.20                 
  M165       RV   (C)~20~AAATATTTCAGGTAAAACCACTCTATTAGTA           51            0.40                 
  M123       FW   (C)~27~AAAGTCACAGTATCTGAACTAGCATATCA             56            0.80                 
  M34        FW   (GACT)~7~(C)~13~GCCTGGCTTCCACCCAGGAG             61            0.20                 
  M136       RV   (GACT)~8~(C)~12~GGTGAGCAGCATTGAGGAAGAC           66            0.10                 
  M281       RV   (GACT)~8~(C)~11~AGGTTGCACAAACTCAGTATTATTAAAC     71            0.80                 

SNP, single nucleotide polymorphism; FW, forward orientation; RV, reverse orientation

While the generation of aspecific peaks did occur occasionally, this was usually due to insufficient purification of the PCR products resulting in the incorporation of the PCR primers or deoxyribonucleotide triphosphates (dNTPs) into the SBE reaction. The presence of one permanent aspecific peak did occur, however, in the Hg-B2b assay (a red peak between the P8 and M211 peaks). This peak seemed to be linked to the P7 primer, perhaps due to a problem during its synthesis, and was usually more visible when overall peak height was decreased.

In order to intensify peak heights, the number of cycles in the SBE reaction program was increased from 25 to 35. While overall peak height improved, variability of peak heights within some assays was unavoidable, despite the adjustment of relative SBE primer concentrations. This was possibly influenced by the efficiency of interaction between SBE primers and template sequences.

Validation of SBE assays
------------------------

The seven SBE assays were validated using samples whose haplogroup status was previously determined. A total of 683 samples were then screened. Additionally, sequencing was performed to confirm the presence of alleles for 15 mutations not screened for before the use of these SBE assays. These included M14, M114, M152, P6, P7, P8, M33, M44, M85, M58, M154, M34, M201, M198 and M343.

The marker M91, in the Hg-A assay, is a homopolymer length variant associated with a single base deletion in a poly-T tract \[[@B13]\]. While the use of SBE in the screening of homopolymer variants is not common, the detection of the M91 mutation using the SBE method was successful. This was reaffirmed phylogenetically \[[@B14],[@B15]\] by the presence of this mutation exclusively in samples belonging to subclades of haplogroup A.

The validation process resulted in the redesign of just two SBE primers, P28 and M35. The initial P28 SBE primer did not pick up the mutation, probably due to non-specific primer binding, while the initial M35 primer resulted in an extremely low peak height when the mutation was present. This was possibly due to the preferential amplification of the ancestral allele, or a lower efficiency of binding by the original SBE primer.

Finally, in haplogroups B2b4\* and B2b4b, P7 showed the presence of two different extension products, displaying both the ancestral and derived states, simultaneously. This also occurred in haplogroup B2b4a, with P8, additionally, exhibiting the same property. The presence of both states was confirmed when sequencing was performed. Thus, it is likely that all samples in haplogroups B2b4\*, B2b4a and B2b4b will display two peaks at the relevant markers. This was, probably, a consequence of these markers being located within paralogous sequence variants \[[@B16]\]. It should be noted that such mutations are more susceptible to back-mutation through gene conversion, as it was with P25 \[[@B17]\]. For this reason, more stable markers that resolve these subclades of B2b4 would be preferable.

Haplogroup assignment using SBE assays
--------------------------------------

The sample of 683 males screened using the seven SBE assays was assigned to 26 of the 61 haplogroups that the assays collectively resolved (see Table [3](#T3){ref-type="table"} and Figure [2](#F2){ref-type="fig"}). The subclades of haplogroup A were found most commonly in the KS, at a frequency of 44.3%. Haplogroup A3b1 was the commonest (28.4%) and was also found to be present in the BAN at low levels (5.0%). The haplogroups A2\*, A2a and A2b were found to be unique to the KS at frequencies of 2.7%, 4.4% and 8.7%, respectively. Haplogroup B was present at moderate frequencies in both the KS and the BAN. Its subclades, however, displayed differing distributions, with haplogroup B2a1a occurring at a substantially higher frequency in the BAN (16.0%) than in the KS (0.5%). The situation was reversed with regard to haplogroup B2b, with its subclades together constituting 10.9% of KS individuals, as compared to 0.3% in the BAN. Haplogroup E was the most common haplogroup in the BAN group (78.1%), with its subclades E1b1a\* and E1b1a7 occurring at frequencies of 34.1% and 25.9%, respectively. While both these haplogroups occurred in the KS at 13.1% and 7.7%, respectively, the most frequent E subclade amongst the KS was E1b1b1\* (15.8%). Haplogroups E2\* and E2b1 were found at much higher frequencies (10.2% versus 1.6%) in the BAN compared with the KS. The haplogroups shared between the BAN and KS, described above, showed extremely significant differences in frequency between the two groups (Fisher\'s exact test: *P*\< 0.0001; for haplogroup E2: *P*= 0.0001). Both the KS and the BAN showed low levels (3.3% and 0.6%, respectively) of assimilation of the Eurasian Y chromosome haplogroups I, K\* (x R), R1a1, and R1b.

###### 

Y chromosome haplogroup frequencies in south eastern Bantu speakers, Khoe-San, and South African Whites.

  Marker   Haplogroup                                                           South eastern Bantu-speakers   (%)    Khoe-San   (%)    South African Whites   (%)
  -------- -------------------------------------------------------------------- ------------------------------ ------ ---------- ------ ---------------------- ------
  M14      A2\* (x A2a, A2b)                                                                                          5          2.7                           
  M114     A2a                                                                                                        8          4.4                           
  P28      A2b                                                                                                        16         8.7                           
  M51      A3b1                                                                 17                             5.0    52         28.4                          
  M152     B2a1a                                                                55                             16.0   1          0.5                           
  M112     B2b\* (x B2b1, B2b2, B2b3, B2b4)                                     1                              0.3    2          1.1                           
  P6       B2b1                                                                                                       13         7.1                           
  P8       B2b4a                                                                                                      5          2.7                           
  M40      E\* (x E1a, E1b1, E2)                                                1                              0.3                                             
  M44      E1a1                                                                                                                         1                      0.6
  M2       E1b1a\* (x E1b1a1, E1b1a2, E1b1a3, E1b1a4, E1b1a5, E1b1a6, E1b1a7)   117                            34.1   24         13.1   1                      0.6
  M58      E1b1a1                                                               11                             3.2    2          1.1                           
  M154     E1b1a4                                                               10                             2.9    2          1.1                           
  M191     E1b1a7                                                               89                             25.9   14         7.7                           
  M35      E1b1b1\* (x E1b1b1a, E1b1b1b, E1b1b1c, E1b1b1d)                      5                              1.5    29         15.8   2                      1.3
  M78      E1b1b1a                                                                                                                      12                     7.6
  M34      E1b1b1c1\* (x E1b1b1c1a)                                                                                   1          0.5    1                      0.6
  M75      E2\* (x E2a, E2b1)                                                   4                              1.2    1          0.5                           
  M85      E2b1                                                                 31                             9.0    2          1.1                           
  M89      F\* (x G, H, I, J2, K)†                                                                                                      4                      2.5
  M201     G                                                                                                                            9                      5.7
  M170     I                                                                                                          1          0.5    28                     17.8
  M172     J2                                                                                                                           6                      3.8
  M9       K\* (x R)†                                                           2                              0.6                      2                      1.3
  M198     R1a1                                                                                                       2          1.1    10                     6.4
  M343     R1b                                                                                                        3          1.6    81                     51.6
                                                                                                                                                               
           TOTAL                                                                343                                   183               157                    

^†^Included in the frequencies of haplogroups F\* and K\* are those lineages not included in the SBE assays, but typed using PCR or RFLP assays, namely P12F2 and M70.

![**Clustered column graphs of haplogroup frequencies in south eastern Bantu-speakers (BAN), Khoe-San (KS) and South African Whites (SAW)**.](2041-2223-1-6-2){#F2}

Y chromosomes in the SAW sample were resolved into macro-haplogroup F (89.2%) of which haplogroup R (58.0%) and haplogroup I (17.8%) together accounted for 75.8%. Haplogroup E comprised the rest of the SAW at 10.8%, with its subclade E1b1b1a found at a frequency of 7.6%. These low to moderate levels of E1b1b1 illustrate the spread of the haplogroup and its subclades into southern Europe and the Middle East, where they are often found. Only two SAW samples, however, clearly belonged to African haplogroups (E1a1 and E1b1a\*).

The haplogroup distributions and their relative frequencies in the BAN and the KS were consistent with previous studies which included these populations \[[@B18]-[@B20]\], while those of the SAW were found to correlate strongly with the Western European populations from which the majority are derived \[[@B21]\].

Conclusions
===========

Seven SBE assays containing 60 SNP markers were designed, which allowed for the rapid assignment of samples to Y chromosome haplogroups, more especially those belonging to the major African haplogroups A, B and E. The assays were designed based on markers found in the YCC phylogeny 2003 \[[@B10]\]. Since then many more markers have been discovered that have further resolved the phylogeny \[[@B2]\]. If needed, these new markers could be incorporated into the current SBE assays, thereby increasing resolution. The use of the current SBE assays in screening Y chromosomes, however, has still resulted in increased haplogroup resolution and sample throughput, and at the same time was quicker and made use of less DNA.

Based on the abovementioned haplogroup frequencies, the KS and the BAN populations are discernable from each other with the KS exhibiting significantly higher frequencies of haplogroups A2, A3b1, B2b and E1b1b1. However, the BAN are identifiable by the strong presence of haplogroups B1a1a, E1b1a and E2. The SAW were appreciably different from both the KS and BAN. There were, however, considerable levels of admixture between the populations (especially the KS and BAN) due to their history of interaction. Consequently, while the elucidation of Y chromosome haplogroups is useful in African populations for both anthropological and forensic purposes, their use together with Y chromosome STR screening would considerably improve resolution and thus refine an individual\'s geographic ancestry.

Methods
=======

DNA samples
-----------

DNA samples from 683 individuals with diverse ethnic backgrounds were analysed in the present study. All DNA samples were collected with the subjects\' informed consent, and this research was approved by the Human Research Ethics Committee (Medical) at the University of the Witwatersrand, Johannesburg (Protocol No. M050906). The sample included 383 south eastern Bantu speakers (BAN), 183 Khoe-San (KS) and 157 South African Whites (SAW).

DNA extraction
--------------

DNA from EDTA-blood was extracted using the salting-out method described by Miller *et al.*\[[@B22]\] and the Gentra Puregene Buccal Cell Kit (Qiagen, Germany) was used to extract DNA from buccal swabs according to the manufacturer\'s instructions. DNA was quantified using the NanoDrop ND-1000 Spectrophotometer (LabVIEW^®^, Coleman Technologies Inc, FL, USA) and diluted to 10 ng/μL using double distilled water.

Primer design
-------------

The sequences of the regions encompassing the polymorphisms were taken from GenBank. The PCR and SBE primers were designed using Primer3 software \[[@B23]\], before aligning them to human genomic sequences using the National Center for Biotechnology Information basic local alignment search tool (BLAST) in order to confirm template specificity. The screening software, AutoDimer \[[@B24]\] was used to check for primer-dimer and hairpin loop formation. High-performance liquid chromatography-purified primers were purchased via Roche from Metabion (Martinsried, Germany), diluted to 100 μM and frozen.

PCR primer lengths ranged from 20 to 27 mers and GC percentage varied between 30% and 60%. Amplicons were designed to differ slightly in size in order to distinguish them following agarose gel electrophoresis to check the success of the PCR. In total, 53 pairs of PCR primers were designed encompassing all 60 SNPs (see Table [1](#T1){ref-type="table"}). Fewer pairs of primers were needed, as some SNPs were co-amplified on the same amplicons (M13 and M14; M40 and M41; M58 and M155; M123 and M281; M81 and M154; M85, M148 and M149).

Poly-C or Poly-GACT tails of differing lengths were added to the 5\' end of most SBE primers (Table [2](#T2){ref-type="table"}), so as to differentiate between them during capillary electrophoresis. SBE primer lengths ranged from 25 to 80 mers, and differed in size from each other by 4-5 mers.

Multiplex PCRs
--------------

Primer design was verified by performing simplex PCR, using a GeneAmp PCR system 9700 (Applied Biosystems, CA, USA), for each of the primer pairs. Thereafter, the multiplex PCRs were optimized to work with DNA at a concentration of 10 ng/μl (see Table [4](#T4){ref-type="table"}), and were catalysed using FastStart Taq DNA Polymerase (Roche, Basel, Switzerland). Relative primer concentrations were adjusted in order to obtain balanced amplification of amplicons within each multiplex. The thermal cycler programmes were as follows: one cycle at 95°C for 6 min, 35 cycles at 95°C for 30 s, 54°C (for YSNP1), 55°C (for Hg-A, Hg-B, Hg-B2b, Hg-E and Hg-E1b1a) or 61°C (for Hg-E1b1b1) for 30 s, extending at 72°C for 30 s and a final extension of 72°C for 10 min. Following the optimization procedures, all multiplex PCRs produced the required amplification products at adequate yields. This was confirmed by running 5 μL of multiplex PCR product on a 2% Metaphore^®^agarose gel (Cambrex, NJ, USA).

###### 

Polymerase chain reaction (PCR) reagent mixtures for multiplex single base extension assays.

  PCR reagent              YSNP1               Hg-A                Hg-B                Hg-B2b
  ------------------------ ------------------- ------------------- ------------------- ------------------
  DNA                      10 ng/μL            10 ng/μL            10 ng/μL            10 ng/μL
  Buffer (10×)             1×                  0.8×                1×                  1×
  MgCl~2~(25 mM)           2 mM                4 mM                3 mM                3 mM
  dNTPs 2.5 mM)            300 μM              200 μM              200 μM              200 μM
  Forward primer (10 μM)   See Table 1         See Table 1         See Table 1         See Table 1
  Reverse primer (10 μM)   See Table 1         See Table 1         See Table 1         See Table 1
  FastStart Taq (5 U/μL)   1 U                 1 U                 1 U                 1 U
  ddH~2~O                  Made up to 25 μL    Made up to 25 μL    Made up to 25 μL    Made up to 25 μL
                                                                                       
                           **Hg-E**            **Hg-E1b1a**        **Hg-E1b1b1**       
                                                                                       
  **PCR reagent**          **Concentration**   **Concentration**   **Concentration**   
                                                                                       
  DNA                      10 ng/μL            10 ng/μL            10 ng/μL            
  Buffer (10×)             1.25×               1.25×               1.25×               
  MgCl~2~(25 mM            3 mM                3 mM                3 mM                
  dNTPs (2.5 mM)           200 μM              200 μM              200 μM              
  Forward primer (10 μM)   See Table 1         See Table 1         See Table 1         
  Reverse primer (10 μM)   See Table 1         See Table 1         See Table 1         
  FastStart Taq (5 U/μL)   1 U                 1 U                 1 U                 
  ddH~2~O                  Made up to 25 μL    Made up to 25 μL    Made up to 25 μL    
                                                                                       

dNTP, deoxyribonucleotide triphosphate; ddH~2~0, double distilled water

Multiplex SBE
-------------

Excess PCR primers and dNTPs were eliminated from the PCR product mixture, following amplification, using an enzymatic purification method. One unit of Exonuclease I (*Exo I*) and 0.5 units of Shrimp Alkaline Phosphatase (SAP) were added to 5 μL of amplification product and the resultant mixture incubated for 1 h at 37°C, followed by 15 min at 75°C.

The multiplex SBE reactions were performed in a final volume of 5 μL, comprised of 1.5 μL purified amplification product, 1.5 μL of double distilled water, 1 μL of SNaPshot Multiplex Ready Reaction Mix (Applied Biosystems) and 1 μL of SBE primer mix, specific to the assay being conducted (see Table [2](#T2){ref-type="table"} for final primer concentrations). The thermal cycler programme was as follows: 96°C for 10 s, 50°C for 5 s and 60°C for 30 s for 35 cycles.

Following the SBE reaction, excess dideoxyribonucleotide triphosphates (ddNTPs) were removed through the addition of 0.5 U of SAP to the 5 μL SBE product. The mixture was incubated for 1 h at 37°C, followed by 15 min at 75°C.

Capillary electrophoresis
-------------------------

Following post-extension treatment, 2 μL of SBE product was mixed with 0.5 μL of the internal size standard, GS120LIZ (Applied Biosystems) and 7.5 μL Hi-Di formamide (Applied Biosystems). This was then run on a 3130*xl*Genetic Analyzer (Applied Biosystems). The SNaPshot protocol was originally optimized for use with POP-4 polymer; modifications recommended by Applied Biosystems were incorporated for use of the POP-7 polymer (Applied Biosystems Manual P/N: 4367258). The resultant electropherograms (Figure [1](#F1){ref-type="fig"}) were analysed using GeneMapperID v3.2 software (Applied Biosystems).

Assay validations
-----------------

Some of the markers used in the SBE assays were validated using a set of control samples, previously screened using RFLP assays. Those markers for which samples of known haplogroup were unavailable were sequenced in order to confirm the presence of the polymorphism. After the screening of the 683 samples, Fisher\'s exact tests were performed using GraphPad InStat version 3.10 32 bit for Windows (GraphPad Software, CA, USA, <http://www.graphpad.com>), in order to test significance of differences in haplogroup frequency between the BAN and KS.
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